Tumor regression responses in melanoma patients treated with a peptide encoded by gene <i>MAGES‐3</i>
M. Marchand(Ludwig Cancer Research), P. Weynants(Ludwig Cancer Research), Elaine M. Rankin(The Netherlands Cancer Institute), Flavio Arienti(Fondazione IRCCS Istituto Nazionale dei Tumori), Filiberto Belli(Fondazione IRCCS Istituto Nazionale dei Tumori), Giorgio Parmiani(Fondazione IRCCS Istituto Nazionale dei Tumori), N. Cascinelli(Fondazione IRCCS Istituto Nazionale dei Tumori), A Bourlond(Cliniques Universitaires Saint-Luc), Remain Vanwuck(UCLouvain), Yves Humblet(UCLouvain), J.‐L. Canon(Grand Charleroi Hospital), Claudine Laurent(Clinique Saint Jean), Jean Naeyaert(Universitair Ziekenhuis Brussel), R Plagne(Centre Jean Perrin), R. Deraemaeker(Institut Jules Bordet), A. Knuth(Krankenhaus Nordwest), Elke Jäger(Krankenhaus Nordwest), F. Brasseur(UCLouvain), Jean Herman(Ludwig Cancer Research), P. G. Couiae(Ludwig Cancer Research), Thierry Boon(Ludwig Cancer Research)
Cited by 419
Abstract
SCOPUS: ar.j
Related Papers
No related papers found
Powered by citation graph analysis